Thoracic Tumor
5
3
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 5 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
Repeat CT for Evaluation of Inter- and Intrafraction Changes During Curative Thoracic Radiotherapy
Detection of (Sub)Clinical Toxicity in Irradiated vs. Non-irradiated Surgically Treated Esophageal Cancer Patients: a Pilot Study (CROSS SECT)
Pelvic Cancer Registry for Online Adapted Radiotherapy
Safety and Efficacy of SBRT in the Reirradiation for Ultra-central Thoracic Malignant Tumors